Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Torre

Showing results (191-200 of 196) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 196 results.
JAMA Dermatology|April 9, 2025
Immune Checkpoint Inhibitor-Induced LipodystrophyJulia Riganti, Ana C Torre, Pietro Sollena, et al.
Rheumatology (Oxford, England)|June 25, 2011
High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study)Federico Navarro-Sarabia, José L Fernández-Sueiro, Juan C Torre-Alonso, et al.
Leukemia|September 20, 2017
14-3-3ζ binds the proteasome, limits proteolytic function and enhances sensitivity to proteasome inhibitorsY Gu, K Xu, C Torre, et al.
Reumatologia Clinica|March 13, 2017
Development of a checklist for patients with axial spondyloarthritis and psoriatic arthritis in daily practice: ONLY TOOLS projectRaquel Almodovar, Juan C Torre Alonso, Enrique Batlle, et al.
Medicina|August 28, 2021
[Dermatological emergencies. Prospective and multicentric study in Argentina]Patricia A Fernández Pardal, Ana C Torre, Agustina Rodrigo, et al.
The British Journal of Dermatology|July 21, 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer PatientsVasiliki A Nikolaou, Zoe Apalla, Cristina Carrera, et al.
Pageof 20

Showing results (191-200 of 196) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 196 results.
JAMA Dermatology|April 9, 2025
Immune Checkpoint Inhibitor-Induced LipodystrophyJulia Riganti, Ana C Torre, Pietro Sollena, et al.
Rheumatology (Oxford, England)|June 25, 2011
High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study)Federico Navarro-Sarabia, José L Fernández-Sueiro, Juan C Torre-Alonso, et al.
Leukemia|September 20, 2017
14-3-3ζ binds the proteasome, limits proteolytic function and enhances sensitivity to proteasome inhibitorsY Gu, K Xu, C Torre, et al.
Reumatologia Clinica|March 13, 2017
Development of a checklist for patients with axial spondyloarthritis and psoriatic arthritis in daily practice: ONLY TOOLS projectRaquel Almodovar, Juan C Torre Alonso, Enrique Batlle, et al.
Medicina|August 28, 2021
[Dermatological emergencies. Prospective and multicentric study in Argentina]Patricia A Fernández Pardal, Ana C Torre, Agustina Rodrigo, et al.
The British Journal of Dermatology|July 21, 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer PatientsVasiliki A Nikolaou, Zoe Apalla, Cristina Carrera, et al.
Pageof 20